Market Research Reports- Consulting Analysis Crystal Market Research Synthetic Biology Market | Page 2

demand for synthetic genes are set to drive this market. On the other hand, stringent regulations related to
bio-safety & bio-security can restrict the growth of this market.
In 2016, enabled product segment occupied the major share of the global synthetic biology market owing to
growing demand for higher-value specialty products. Besides, core product will grow at highest CAGR during
the forecast period owing to increasing use of synthetic genes and development of DNA constructs.
Healthcare segment occupied the major share of the overall synthetic biology market in 2016 owing to high
usage in developing economical drugs and vaccines.
In 2016, Europe occupied the major share of the synthetic biology market owing to rising government
funding and increased R&D efforts. On the other hand, Asia-Pacific is projected to witness significant growth
in the forecast period.
Strategic collaborations is the key strategy adopted by the leading players in the market. For instance, in May
2017, Oxford Genetics (a leading synthetic biology-based technology company) entered into a non-exclusive
licensing agreement with ERS Genomics. This agreement grants Oxford Genetics to access ESR’s foundational
intellectual property about CRISPR/Cas9 gene editing technology. Similarly, in May 2016, Bayer and ESR
Genomics entered into a patent license agreement. As per the terms of agreement, Bayer obtained access to
ESR’s genome editing patent portfolio (i.e. CRISPR-Cas9) for cross divisional applications in its strategic
business areas.
Request a sample copy of Synthetic Biology Market Research Report @
https://www.crystalmarketresearch.com/report-sample/HC06129
Some of the leading players in the global synthetic biology market are New England Biolabs, Inc., Synthetic
Genomics Inc., Integrated DNA Technologies, Inc.,DuPont,Amyris, Inc., GenScript, Intrexon Corporation,
Gingko Bioworks, Thermo Fisher Scientific Inc., Intrexon Corporation, and Agilent Technologies, Inc.
Key Findings of the Research Study:




Enabled product segment accounted for the largest share of the overall market in 2016
Core product category is poised to be the fastest-growing segment during the forecast period
Europe dominated the global market for synthetic biology in 2016 due to increased R&D efforts for
the development of synthetic biology products
Asia-Pacific is expected to grow at double digit CAGR during the forecast period due to high demand
for synthetically manufactured crops and rising awareness about synthetic biology
Inquire more about this report at: https://www.crystalmarketresearch.com/send-an-
enquiry/HC06129
Synthetic Biology Market Segmentation:
By Product: